Weekly Drug News : January 16, 2019

The resurgence of whooping cough is an ongoing concern in the U.S., and this week the FDA cleared Adacel as first Tdap vaccine for repeat vaccination. Plus, Cabometyx gains a new use in aggressive liver cancer. Researchers at Georgia Tech are using microneedle techniques to develop birth control, and a reality check on cervical cancer screening is posted. Finally, first-time generics, like Teva’s newly approved seizure drug vigabatrin, are a top FDA priority.



Recent Posts

See All

Admin Login by RSP

Admin Login by Center Team

Dear Visitors !

Articles written by authors are their views and their presentation of ideas and knowledge. CHEARS does not claim right on write-up and authors are the real owner and are responsible for their write-up or views. Posts from CHEARS News Room are interpretations or presentation of news from various news resources. 

Posts from executive committee members are posts from CHEARS Office.  

© Copyright CHEARS

© Center for Health Education, Awareness Resources and Services

Subscribe to Our Newsletter